We are live on ! Find out more
Citadel Advisors

Citadel Advisors Portfolio holdings

AUM $875B
1-Year Est. Return 40.91%
 

Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.

This Fund
S&P 500
This Quarter Est. Return
-13.42%
1 Year Est. Return
+40.91%
3 Year Est. Return
+115.85%
5 Year Est. Return
+132.1%
10 Year Est. Return
+518.81%
AUM
$390B
AUM Growth
-$94.7B
Cap. Flow
+$10.4B
Cap. Flow %
2.66%
Top 10 Hldgs %
28.21%
Holding
14,957
New
1,520
Increased
5,503
Reduced
5,522
Closed
2,191

Sector Composition

Rank Sector Weight
1 Healthcare 2.83%
2 Technology 2.79%
3 Financials 2.29%
4 Consumer Discretionary 1.93%
5 Industrials 1.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RCUS icon
5001
PUT
Arcus Biosciences
RCUS
$3.75B
$2.51M ﹤0.01%
98,900
+86,500
+698% +$2.12M
WIRE
5002
PUT
DELISTED
Encore Wire Corp
WIRE
$2.5M ﹤0.01%
24,100
-26,900
-53% -$3.18M
RSI icon
5003
Rush Street Interactive
RSI
$2.96B
$2.5M ﹤0.01%
535,857
-239,155
-31% -$1.42M
RXRX icon
5004
Recursion Pharmaceuticals
RXRX
$1.69B
$2.5M ﹤0.01%
307,372
-602,598
-66% -$4.03M
VCR icon
5005
CALL
Vanguard Consumer Discretionary ETF
VCR
$6.11B
$2.5M ﹤0.01%
11,000
+800
+8% +$209K
OBIO icon
5006
Orchestra BioMed
OBIO
$265M
$2.5M ﹤0.01%
250,968
-10,626
-4% -$106K
CDXS icon
5007
Codexis
CDXS
$171M
$2.5M ﹤0.01%
238,929
-45,883
-16% -$575K
HCCI
5008
DELISTED
Heritage-Crystal Clean, Inc.
HCCI
$2.5M ﹤0.01%
92,668
+36,743
+66% +$998K
SWIM icon
5009
Latham Group
SWIM
$861M
$2.5M ﹤0.01%
360,046
-287,224
-44% -$3.05M
PING
5010
DELISTED
Ping Identity Holding Corp.
PING
$2.5M ﹤0.01%
137,567
-207,212
-60% -$4.61M
MTBL
5011
CALL
DELISTED
Moatable, Inc. American Depositary Share (each representing forty-five (45) Class A Ordinary Shares)
MTBL
$2.49M ﹤0.01%
862,000
-359,000
-29% -$988K
CRNX icon
5012
CALL
Crinetics Pharmaceuticals
CRNX
$8.99B
$2.49M ﹤0.01%
+133,600
New +$2.67M
IDU icon
5013
iShares US Utilities ETF
IDU
$1.38B
$2.49M ﹤0.01%
29,114
+26,061
+854% +$2.3M
NABL icon
5014
N-able
NABL
$650M
$2.49M ﹤0.01%
276,814
-146,287
-35% -$1.43M
FSK icon
5015
CALL
FS KKR Capital
FSK
$3.42B
$2.49M ﹤0.01%
128,200
+115,400
+902% +$2.45M
CBU icon
5016
Community Bank
CBU
$3.46B
$2.49M ﹤0.01%
39,322
-5,146
-12% -$337K
IDLV icon
5017
Invesco S&P International Developed Low Volatility ETF
IDLV
$345M
$2.49M ﹤0.01%
90,101
-53,465
-37% -$1.58M
CNCE
5018
DELISTED
Concert Pharmaceuticals, Inc.
CNCE
$2.49M ﹤0.01%
591,124
+570,731
+2,799% +$2.26M
PETQ
5019
DELISTED
PetIQ, Inc. Class A Common Stock
PETQ
$2.49M ﹤0.01%
148,097
-53,223
-26% -$976K
GPMT
5020
Granite Point Mortgage Trust
GPMT
$57.4M
$2.49M ﹤0.01%
259,771
+217,652
+517% +$2.22M
SWBI icon
5021
Smith & Wesson
SWBI
$643M
$2.48M ﹤0.01%
189,219
+26,609
+16% +$386K
UDMY
5022
DELISTED
Udemy
UDMY
$2.48M ﹤0.01%
243,234
-756,763
-76% -$9.17M
KRTX
5023
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
$2.48M ﹤0.01%
19,619
+2,931
+18% +$337K
KEEL
5024
Keel Infrastructure Corp
KEEL
$2.17B
$2.48M ﹤0.01%
2,215,491
+1,158,259
+110% +$2.63M
TMPO
5025
CALL
DELISTED
Tempo Automation Holdings, Inc. Common Stock
TMPO
$2.48M ﹤0.01%
244,400
+199,000
+438% +$2M

Similar funds

Citadel Advisors's Q2 2022 Portfolio in Review

As of Q2 2022, Citadel Advisors held 14,957 positions worth $390B, down 20% from $484B the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Citadel Advisors's Q2 2022 filing shows 1,520 new, 5,503 increased, 5,522 reduced and 2,191 closed positions. Its largest new stake was ResMed: 1,280,595 shares worth $268M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $576M.

By sector, the portfolio is most concentrated in Healthcare at 2.8% of assets, up from 2.4% a quarter earlier, followed by Technology and Financials.

  • Citadel Advisors's largest Q2 2022 buy was ResMed: 1,280,595 shares worth $268M.
  • Citadel Advisors added most to Meta Platforms (Facebook) in Q2 2022, an estimated $772M increase.
  • Citadel Advisors's biggest Q2 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $576M.
  • Citadel Advisors fully exited Vanguard Morningstar Small-Cap ETF in Q2 2022, selling an estimated $184M.
  • Citadel Advisors's ten largest holdings make up 28% of its $390B portfolio in Q2 2022.
  • Citadel Advisors opened 1,520 new positions and closed 2,191 in Q2 2022.
  • Citadel Advisors's portfolio value fell 20% quarter-over-quarter to $390B.

Based on Citadel Advisors's 13F filing for Q2 2022, filed 15 Aug 2022.